Log In
BCIQ
Print this Print this
 

PEG-C1 esterase inhibitor (BEL-0215) (formerly EZN-3008)

  Manage Alerts
Collapse Summary General Information
Company Belrose Pharma Inc.
DescriptionPEGylated form of plasma-derived complement 1 (C1) esterase inhibitor
Molecular Target Complement 1 (C1) esterase
Mechanism of ActionComplement 1 (C1) esterase inhibitor
Therapeutic ModalitySmall molecule
Latest Stage of DevelopmentIND
Standard IndicationAngioedema
Indication DetailsTreat hereditary angioedema
Regulatory Designation
Partner

 Product Details
 Archive Items are loading loading
Collapse Summary Deals Information
 Deals Details
Get a free BioCentury trial today